Immunology
McDavid Stilwell appointed as CFO of CPTx
April 28, 2025Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics
CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …
AAX Biotech aims to enhance growth with two new appointments
April 10, 2025Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development
AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …
Pharming Group doses first patient in phase 2 trial of leniolisib in CVID
March 26, 2025Clinical Trial Services, Research and Development CVID, Immunology, Pharming Group, clinical trial, common variable immunodeficiency, immunodeficiency
Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in …
Takeda announces launch of Framework to help support patient access to life-extending combination treatments
February 25, 2025Business Services Cancer, HIV/AIDS, Immunology, NHS, NICE, Oncology, Takeda, VPAG, patient access
The Conceptual Implementation Framework outlines critical points within the UK healthcare access ecosystem to help improve the introduction of combination …
Santhera Pharmaceuticals announces LIONHEART study results for corticosteroid vamorolone
October 1, 2024Research and Development Cardiology, Duchenne Muscular Dystrophy, Immunology, Santhera Pharmaceuticals, clinical studies
Santhera Pharma has announced the results of its LIONHEART study, which evaluated vamorolone – a corticosteroid – and confirmed its …
Amferia closes €1,2 million investment to combat resistant bacterial infections
September 3, 2024Research and Development Amferia, Chalmers Ventures, Dressings, hosiery & appliances, Hospital Management, Immunology, antimicrobial, investment, peptides
Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. …
The National Institute for Health and Care Excellence announce technology appraisal guidance recommending risankizumab for adult patients with moderate to severe ulcerative colitis
August 29, 2024Research and Development AbbVie, Crohns, Gastrointestinal tract, Immunology, NICE, approval, ulcerative colitis
The National Institute for Health and Care Excellence (NICE) have recommended adult patients in England or Wales with moderately or …
Pfizer releases results for severe RSV-associated LRTD treatment study
August 13, 2024Clinical Trial Services, Research and Development Immunology, Pfizer, autoimmune, clinical trial, respiratory, vaccines
US-based Pfizer have announced results from its substudy B of the ongoing phase 3 clinical trial into the safety and …
GSK and CureVac to restructure collaboration into licensing agreement
July 3, 2024Sales and Marketing CureVac, GSK, Immunology, License Agreement, collaboration
GSK and CureVac have announced that they have restructured their existing collaboration into a license agreement, which is intended to …
GSK’s Arexvy vaccine approved by FDA for RSV prevention in adult patients
June 10, 2024Medical Communications FDA, GSK, Immunology, Vaccine
GSK has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted) …
BioGen to acquire Human Immunology Biosciences for $1.15bn
May 23, 2024Business Services Biogen, HI-Bio, Immunology, acquisition, immunology
BioGen and Human Immunology Biosciences (HI-Bio) have announced that they have entered into a definitive agreement for Biogen to acquire …
AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug
May 17, 2024Research and Development AstraZeneca, COVID-19, Immunology, clinical trial
AstraZeneca has announced positive high-level results from the SUPERNOVA phase 3 trial for a COVID-19 pre-exposure prophylaxis treatment, sipavibart (formerly …
Moderna shares update on RSV vaccine
May 13, 2024Medical Communications FDA, Immunology, Moderna, Vaccine
Moderna has announced that the US Food and Drug Administration (FDA) has shared that it will not complete its review …
Sanofi and Novavex sign exclusive $1.2bn licensing agreement to co-commercialise COVID-19 vaccine and develop flu-COVID-19 vaccines
May 10, 2024Sales and Marketing COVID-19, COVID-19 vaccine, Immunology, Novatex, Sanofi, flu-COVID-19 vaccine, licensing agreement
French pharma and healthcare company Sanofi and US biotech Novavex, have entered into a co-exclusive licensing agreement for a number …
AstraZeneca withdraws COVID-19 vaccine Vaxzevria
May 9, 2024Sales and Marketing AstraZeneca, COVID-19, Immunology, thrombosis with thrombocytopenia syndrome
UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria due to a drop in …
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
